CSIMarket
 
Allakos Inc   (ALLK)
Other Ticker:  
 

Allakos Inc

Business Description


Allakos Inc. is a biopharmaceutical company based in California that specializes in the development of therapeutic antibodies for the treatment of various immune-mediated diseases. The company was founded in 2012 by Nessa Carion and Dr. Robert Alexander, and went public in 2018 (NASDAQ: ALLK).

Allakos has a unique focus on eosinophilic and mast cell-related diseases, which are conditions that result from the dysfunction of certain types of immune cells. These diseases can be chronic and debilitating, affecting multiple organ systems and leading to a host of complications.

Allakos has several drug candidates in its pipeline, with its lead product, AK002, being tested clinically for several indications, including eosinophilic gastritis and urticaria, chronic rhinosinusitis with nasal polyps, and indolent systemic mastocytosis. AK002 is an antibody that targets the cell surface receptor Siglec-8, which is expressed on eosinophils and mast cells. By binding to Siglec-8, AK002 is thought to reduce the activation and proliferation of these cells, thereby reducing inflammation and symptoms associated with the target diseases.

In addition to AK002, Allakos is also developing two other drug candidates: AK001, which targets a different receptor on mast cells, and AK003, which targets a cytokine called IL-33 that is involved in the activation of mast cells and other immune cells.

Allakos has a robust research program, with a strong focus on identifying new drug targets and developing novel therapies for unmet medical needs. The company has collaborations with academic and industry partners, including the National Institutes of Health, to leverage their expertise and resources.

Overall, Allakos is a dynamic and growing biopharmaceutical company that is making strides in developing new treatments for immune-mediated diseases. Its innovative approach and promising drug candidates have garnered attention from investors, clinicians, and patients alike.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com